Published in J Immunol on November 15, 2006
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol (2009) 3.17
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog (2009) 2.24
Recognition of herpesviruses by the innate immune system. Nat Rev Immunol (2011) 1.96
Pattern recognition receptors and the innate immune response to viral infection. Viruses (2011) 1.82
Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol (2010) 1.78
Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol (2015) 1.66
Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis (2014) 1.59
Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol (2008) 1.57
Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J Gen Virol (2009) 1.56
Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am (2011) 1.42
Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One (2009) 1.31
Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol (2007) 1.31
Innate immune sensing of DNA viruses. Virology (2011) 1.30
Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J Virol (2009) 1.26
Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci U S A (2008) 1.25
Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1. J Virol (2011) 1.21
Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J Virol (2007) 1.18
Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol (2007) 1.17
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-κB. J Virol (2012) 1.16
Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade. PLoS Pathog (2012) 1.11
Recognition of virus infection and innate host responses to viral gene therapy vectors. Mol Ther (2010) 1.10
The immune response to human CMV. Future Virol (2012) 1.10
Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Clin Exp Immunol (2007) 1.09
Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells. J Virol (2007) 1.07
Regulation of B-cell responses by Toll-like receptors. Immunology (2012) 1.07
Recent insights into the role of Toll-like receptors in viral infection. Clin Exp Immunol (2010) 1.06
Multifaceted evasion of the interferon response by cytomegalovirus. J Interferon Cytokine Res (2009) 1.06
Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J (2008) 1.04
Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc Natl Acad Sci U S A (2011) 1.03
Cytomegalovirus in the neonate: immune correlates of infection and protection. Clin Dev Immunol (2013) 1.03
Toll-like receptors in antiviral innate immunity. J Mol Biol (2013) 1.03
αvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion. PLoS Pathog (2013) 0.99
Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression. PLoS One (2012) 0.99
Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology (2011) 0.98
Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis (2012) 0.96
HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood (2009) 0.96
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses (2013) 0.95
Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry. J Virol (2010) 0.95
TLR-mediated preterm birth in response to pathogenic agents. Infect Dis Obstet Gynecol (2010) 0.95
Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol (2011) 0.95
Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination. J Leukoc Biol (2012) 0.94
dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol Rev (2011) 0.93
The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection. Mediators Inflamm (2010) 0.92
The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis (2009) 0.92
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol (2011) 0.92
αvβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1. Proc Natl Acad Sci U S A (2012) 0.92
TRAM is required for TLR2 endosomal signaling to type I IFN induction. J Immunol (2014) 0.91
Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway. PLoS Pathog (2015) 0.91
Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus. Med Microbiol Immunol (2012) 0.90
Controlling cytomegalovirus: helping the immune system take the lead. Viruses (2014) 0.89
Suppression of TLR9 immunostimulatory motifs in the genome of a gammaherpesvirus. J Immunol (2011) 0.88
Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue. Virol J (2007) 0.87
The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. PLoS One (2013) 0.87
Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced Inflammation. Front Immunol (2016) 0.87
The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol (2013) 0.87
Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm (2012) 0.87
Toll-like receptor sensing of human herpesvirus infection. Front Cell Infect Microbiol (2012) 0.86
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. PLoS One (2014) 0.85
The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. J Virol (2014) 0.85
The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens (2016) 0.83
Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev (2010) 0.83
Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Res Notes (2012) 0.83
The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol (2012) 0.82
Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection. J Virol (2014) 0.82
Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis. PLoS One (2010) 0.82
Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus. Oncol Lett (2014) 0.82
New cell-signaling pathways for controlling cytomegalovirus replication. Am J Transplant (2014) 0.81
Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PLoS One (2013) 0.81
THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection. PLoS Pathog (2015) 0.81
HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation. Front Immunol (2015) 0.80
Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front Immunol (2013) 0.80
Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis. Curr Opin Virol (2013) 0.80
Arenavirus evasion of host anti-viral responses. Viruses (2012) 0.79
Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS One (2012) 0.79
[Cytomegalovirus. Pathological-anatomical manifestations and detection methods]. Pathologe (2011) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
The danger is growing! A new paradigm for immune system activation and peripheral tolerance. PLoS One (2009) 0.78
Human herpesviruses-encoded dUTPases: a family of proteins that modulate dendritic cell function and innate immunity. Front Microbiol (2014) 0.78
TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants. PLoS One (2016) 0.78
Interplay between human cytomegalovirus and dendritic cells in T cell activation. Med Microbiol Immunol (2008) 0.78
Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. Mamm Genome (2010) 0.77
Genetic variants of innate immune receptors and infections after liver transplantation. World J Gastroenterol (2014) 0.77
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2. J Virol (2013) 0.77
Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases. Front Immunol (2016) 0.77
TLR2 2258 G>A single nucleotide polymorphism and the risk of congenital infection with human cytomegalovirus. Virol J (2017) 0.76
Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway. Sci Rep (2016) 0.76
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV. Transplantation (2016) 0.76
A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection. PLoS Pathog (2015) 0.76
Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity. Mol Ther (2016) 0.76
Herpesviral infection and Toll-like receptor 2. Protein Cell (2012) 0.76
Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells. Inflammation (2016) 0.76
Cytomegalovirus Vaccines: Current Status and Future Prospects. Drugs (2016) 0.76
Role of cytomegalovirus on the maturation and function of monocyte derived dendritic cells of liver transplant patients. World J Transplant (2016) 0.75
Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women. Virol J (2017) 0.75
Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo. Proc Natl Acad Sci U S A (2016) 0.75
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation. Blood Res (2015) 0.75
Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol (2009) 2.26
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions. Cell Host Microbe (2011) 2.20
Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A (2004) 2.19
Innate sensing of viruses by toll-like receptors. J Virol (2004) 1.70
Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion. J Virol (2005) 1.56
Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS (2008) 1.45
Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion. J Virol (2004) 1.43
Rational development of beta-peptide inhibitors of human cytomegalovirus entry. J Biol Chem (2005) 1.32
Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol (2004) 1.27
Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J Virol (2009) 1.26
Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol (2008) 1.21
Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors. Antimicrob Agents Chemother (2010) 1.21
Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J Virol (2007) 1.21
Multiple cyclophilins involved in different cellular pathways mediate HCV replication. Virology (2009) 1.17
Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol (2011) 1.13
Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance. Antimicrob Agents Chemother (2008) 1.11
More on JC viremia in natalizumab-treated patients with multiple sclerosis. N Engl J Med (2013) 1.09
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc Natl Acad Sci U S A (2011) 1.08
Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells. J Virol (2002) 1.07
Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc Natl Acad Sci U S A (2011) 1.03
The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry. J Virol (2010) 1.01
Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus. J Clin Virol (2002) 0.94
Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1. J Virol (2006) 0.93
Disulfide bond configuration of human cytomegalovirus glycoprotein B. J Virol (2002) 0.92
Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol (2010) 0.90
Increased oxidative stress and anaerobic energy release, but blunted Thr172-AMPKα phosphorylation, in response to sprint exercise in severe acute hypoxia in humans. J Appl Physiol (1985) (2012) 0.89
Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion. Virol J (2011) 0.85
Energy metabolism during repeated sets of leg press exercise leading to failure or not. PLoS One (2012) 0.81
High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells. Antiviral Res (2011) 0.81
Hexokinase 2, glycogen synthase and phosphorylase play a key role in muscle glycogen supercompensation. PLoS One (2012) 0.81
Critical role for free radicals on sprint exercise-induced CaMKII and AMPKα phosphorylation in human skeletal muscle. J Appl Physiol (1985) (2013) 0.81
Analgesia after thoracotomy: epidural fentanyl/bupivacaine compared with intercostal nerve block plus intravenous morphine. J Cardiothorac Vasc Anesth (2004) 0.78
Sarcomere Disruptions of Slow Fiber Resulting From Mountain Ultramarathon. Int J Sports Physiol Perform (2015) 0.77
Upregulation of heart PFK-2/FBPase-2 isozyme in skeletal muscle after persistent contraction. Pflugers Arch (2012) 0.77
Spatial patterns of protein expression in focal infections of human cytomegalovirus. Biotechnol Bioeng (2006) 0.77
Anaerobic energy expenditure and mechanical efficiency during exhaustive leg press exercise. PLoS One (2010) 0.77
Blood ammonia and lactate as markers of muscle metabolites during leg press exercise. J Strength Cond Res (2014) 0.77
A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV. AIDS Behav (2015) 0.76
New cis-clerodane diterpenoids from Croton schiedeanus. Chem Pharm Bull (Tokyo) (2005) 0.75
Symptom control and palliative care in Chile. J Pain Palliat Care Pharmacother (2003) 0.75
Neo-clerodane diterpenoids from Croton schiedeanus. Phytochemistry (2003) 0.75